Blendy J A, Perry D C, Pabreza L A, Kellar K J
Department of Pharmacology, School of Medicine, George Washington University, Washington, D.C. 20007.
J Neurochem. 1991 Nov;57(5):1548-55. doi: 10.1111/j.1471-4159.1991.tb06350.x.
Repeated administration of electroconvulsive shock (ECS) increases [3H]prazosin binding to alpha 1-adrenoceptors in rat cerebral cortex. In contrast, [3H]WB4101 binding in cortex has been reported to be unchanged after ECS. [3H]Prazosin labels two alpha 1-adrenoceptor subtypes, termed alpha 1a and alpha 1b, whereas [3H]WB4101 labels the alpha 1a subtype preferentially. The purpose of this study was to determine whether ECS increases one or both alpha 1-adrenoceptor subtypes in rat cerebral cortex. We found that treatment of rats with ECS once daily for 10-12 days increased [3H]prazosin binding in cortex by about 25% but did not significantly alter [3H]WB4101 binding to alpha 1-adrenoceptors. Measurement of alpha 1a and alpha 1b receptors by competition analysis of the selective alpha 1a antagonist 5-methylurapidil against [3H]prazosin and measurement of [3H]prazosin binding in homogenates preincubated with chlorethylclonidine, which alkylates alpha 1b binding sites, also indicated that the ECS-induced increase in alpha 1-adrenoceptors is confined to the alpha 1b subtype. In contrast to its effect on [3H]prazosin binding, ECS did not increase phosphoinositide hydrolysis as measured by [3H]inositol 1-phosphate accumulation in slices of rat cerebral cortex stimulated by either norepinephrine or phenylephrine. The failure of ECS to increase [3H]inositol 1-phosphate accumulation stimulated by phenylephrine, which is a partial agonist for this response, suggests that spare receptors do not account for the apparent absence of effect of ECS on alpha 1-adrenoceptor-mediated phosphoinositide hydrolysis.
反复给予电惊厥休克(ECS)可增加大鼠大脑皮层中[3H]哌唑嗪与α1 - 肾上腺素能受体的结合。相比之下,据报道ECS后皮层中[3H]WB4101的结合没有变化。[3H]哌唑嗪标记两种α1 - 肾上腺素能受体亚型,称为α1a和α1b,而[3H]WB4101优先标记α1a亚型。本研究的目的是确定ECS是否增加大鼠大脑皮层中的一种或两种α1 - 肾上腺素能受体亚型。我们发现,每天用ECS处理大鼠10 - 12天可使皮层中[3H]哌唑嗪结合增加约25%,但并未显著改变[3H]WB4101与α1 - 肾上腺素能受体的结合。通过选择性α1a拮抗剂5 - 甲基尿嘧啶对[3H]哌唑嗪的竞争分析来测量α1a和α1b受体,并通过对用氯乙可乐定预孵育的匀浆中[3H]哌唑嗪结合进行测量(氯乙可乐定可使α1b结合位点烷基化),这也表明ECS诱导的α1 - 肾上腺素能受体增加仅限于α1b亚型。与它对[3H]哌唑嗪结合的影响相反,ECS并没有增加磷酸肌醇水解,这是通过去甲肾上腺素或苯肾上腺素刺激的大鼠大脑皮层切片中[3H]肌醇1 - 磷酸积累来测量的。ECS未能增加由苯肾上腺素刺激的[3H]肌醇1 - 磷酸积累,苯肾上腺素是这种反应的部分激动剂,这表明备用受体并不能解释ECS对α1 - 肾上腺素能受体介导的磷酸肌醇水解明显无作用的现象。